Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CNS 2a”

191 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 191 results

Testing effectiveness (Phase 2)Study completedNCT00594945
What this trial is testing

Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures

Who this might be right for
Epilepsy
Jazz Pharmaceuticals 45
Testing effectiveness (Phase 2)Study completedNCT05965700
What this trial is testing

NVG-291 in Spinal Cord Injury Subjects

Who this might be right for
Spinal Cord InjuriesChronic Spinal Cord InjurySubacute Spinal Cord Injury
NervGen Pharma 24
Testing effectiveness (Phase 2)Ended earlyNCT03919162
What this trial is testing

A Trial to Evaluate the Efficacy and Safety of PQ912 in Patients With Early AD

Who this might be right for
Alzheimer Disease
Vivoryon Therapeutics N.V. 112
Testing effectiveness (Phase 2)Ended earlyNCT04311515
What this trial is testing

To Evaluate Safety, Tolerability and Pharmacological Effects of PU AD in Subjects With Mild AD Dementia

Who this might be right for
Alzheimer Disease
Samus Therapeutics, Inc. 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT04631406
What this trial is testing

A Safety and Tolerability Study of Neural Stem Cells (NR1) in Subjects With Chronic Ischemic Subcortical Stroke (ISS)

Who this might be right for
Ischemic Stroke
Clarion Cells, Inc. 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT07033481
What this trial is testing

Clinical Study of Neflamapimod in Patients With Primary Progressive Aphasia

Who this might be right for
Nonfluent Variant Primary Progressive Aphasia (nfvPPA)
EIP Pharma Inc 20
Testing effectiveness (Phase 2)Looking for participantsNCT05822908
What this trial is testing

A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD

Who this might be right for
Spinocerebellar Ataxia Type 1Spinocerebellar Ataxia Type 3Huntington Disease
Vico Therapeutics B. V. 68
Testing effectiveness (Phase 2)UnknownNCT02369926
What this trial is testing

Endpoint Calibration for a Phase 2 Study of Lisinopril in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Transparency Life Sciences 20
Early research (Phase 1)Enrolling By InvitationNCT06344026
What this trial is testing

Phase 1/2a Study of ANPD001 in Parkinson Disease

Who this might be right for
Parkinson Disease
Aspen Neuroscience 9
Testing effectiveness (Phase 2)Study completedNCT04683848
What this trial is testing

Study to Assess the Efficacy and Safety of MT-3921 in Subjects With Acute Traumatic Cervical Spinal Cord Injury

Who this might be right for
Spinal Cord Injury
Tanabe Pharma America, Inc. 72
Testing effectiveness (Phase 2)Study completedNCT07047209
What this trial is testing

Trial of Oral Digoxin in Individuals With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)
Massachusetts General Hospital 41
Testing effectiveness (Phase 2)Ended earlyNCT02530307
What this trial is testing

HT-3951 vs. Placebo in Stroke Rehabilitation

Who this might be right for
Ischemic Stroke
Dart NeuroScience, LLC 61
Testing effectiveness (Phase 2)Looking for participantsNCT06752720
What this trial is testing

Intracerebral Autologous Stem Cell Therapy for Chronic Stroke Patients

Who this might be right for
StrokeStroke, IschemicStroke; Sequelae
Hokkaido University Hospital 8
Testing effectiveness (Phase 2)Study completedNCT02462603
What this trial is testing

Safety and Biomarker Study of PTC-589 in Participants With Parkinson's Disease

Who this might be right for
Parkinson's Disease
Edison Pharmaceuticals Inc 44
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06990984
What this trial is testing

A Dose-ranging Study of TTI-0102 in Adults and Children With Leigh Syndrome Spectrum (LSS)

Who this might be right for
Leigh Syndrome
Thiogenesis Therapeutics, Inc. 18
Testing effectiveness (Phase 2)Ended earlyNCT00735085
What this trial is testing

A Phase 2a Dose Escalation Study With SLV334 in Patients With Traumatic Brain Injury.

Who this might be right for
Traumatic Brain Injury
Abbott Products 57
Testing effectiveness (Phase 2)Study completedNCT01854294
What this trial is testing

GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Genervon Biopharmaceuticals, LLC 12
Testing effectiveness (Phase 2)UnknownNCT02149160
What this trial is testing

Study to Assess the Safety, Tolerability, and Pharmacodynamic (PD) Effects of FRM-0334 in Subjects With Prodromal to Moderate Frontotemporal Dementia With Granulin Mutation

Who this might be right for
Granulin Mutation
FORUM Pharmaceuticals Inc 30
Early research (Phase 1)WithdrawnNCT02791919
What this trial is testing

Wee1 Kinase Inhibitor AZD1775 and Combination Chemotherapy in Treating Children, Adolescents and Young Adults With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
CNS 2aCNS 2bCNS 2c+3 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT05161715
What this trial is testing

Proof-of-concept, Open-label Study in Patients With Early Alzheimer's Disease

Who this might be right for
Early Alzheimer's Disease
NewAmsterdam Pharma 13
Next Page